| 1 | Limiting Premenstrual Endometrial Hypoxia Inducible Factor 2 Alpha May Fine-Tune Endometrial Function at Menstruation | 4.4 | 1 | Citations (PDF) |
| 2 | Endothelial dysfunction in the aging kidney | 3.4 | 1 | Citations (PDF) |
| 3 | Fatty acid oxidation fuels natural killer cell responses against infection and cancer | 7.7 | 10 | Citations (PDF) |
| 4 | FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4 | 7.2 | 2 | Citations (PDF) |
| 5 | Functional synergy of a human-specific and an ape-specific metabolic regulator in human neocortex development | 14.1 | 7 | Citations (PDF) |
| 6 | Weak neuronal glycolysis sustains cognition and organismal fitness | 11.9 | 9 | Citations (PDF) |
| 7 | The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells | 4.5 | 1 | Citations (PDF) |
| 8 | Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance | 13.9 | 14 | Citations (PDF) |
| 9 | Single-cell atlas of the human brain vasculature across development, adulthood and disease | 40.1 | 21 | Citations (PDF) |
| 10 | GAS6 and AXL Promote Insulin Resistance by Rewiring Insulin Signaling and Increasing Insulin Receptor Trafficking to Endosomes | 0.5 | 0 | Citations (PDF) |
| 11 | Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation | 14.1 | 1 | Citations (PDF) |
| 12 | Immunomodulation by endothelial cells: prospects for cancer therapy | 14.0 | 0 | Citations (PDF) |
| 13 | Glucose metabolism controls monocyte homeostasis and migration but has no impact on atherosclerosis development in mice | 14.1 | 0 | Citations (PDF) |
| 14 | Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives | 5.6 | 29 | Citations (PDF) |
| 15 | The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution | 5.6 | 21 | Citations (PDF) |
| 16 | Repair of airway epithelia requires metabolic rewiring towards fatty acid oxidation | 14.1 | 17 | Citations (PDF) |
| 17 | Shaping the brain vasculature in development and disease in the single-cell era | 10.0 | 52 | Citations (PDF) |
| 18 | Prioritization and functional validation of target genes from single-cell transcriptomics studies | 4.5 | 2 | Citations (PDF) |
| 19 | Understanding tumour endothelial cell heterogeneity and function from single-cell omics | 24.2 | 58 | Citations (PDF) |
| 20 | Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition | 11.9 | 52 | Citations (PDF) |
| 21 | VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway | 26.3 | 19 | Citations (PDF) |
| 22 | Targeting hypoxia-inducible factors: therapeutic opportunities and challenges | 39.3 | 46 | Citations (PDF) |
| 23 | Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling | 5.6 | 16 | Citations (PDF) |
| 24 | Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension | 5.6 | 61 | Citations (PDF) |
| 25 | Identification of vascular cues contributing to cancer cell stemness and function | 7.4 | 12 | Citations (PDF) |
| 26 | De novo serine synthesis regulates chondrocyte proliferation during bone development and repair | 14.1 | 25 | Citations (PDF) |
| 27 | Immunomodulation by endothelial cells — partnering up with the immune system? | 17.9 | 210 | Citations (PDF) |
| 28 | Mitochondrial respiration supports autophagy to provide stress resistance during quiescence | 13.8 | 20 | Citations (PDF) |
| 29 | Author response: Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes 2022, , | | 0 | Citations (PDF) |
| 30 | A Role for the Vascular Endothelium in Post–Acute COVID-19? | 19.4 | 16 | Citations (PDF) |
| 31 | Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis | 14.1 | 26 | Citations (PDF) |
| 32 | PHGDH heterogeneity potentiates cancer cell dissemination and metastasis | 40.1 | 115 | Citations (PDF) |
| 33 | A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth | 11.9 | 40 | Citations (PDF) |
| 34 | Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level | 14.1 | 31 | Citations (PDF) |
| 35 | Endothelial cell heterogeneity and plasticity in health and disease—new insights from single-cell studies 2022, , 17-28 | | 1 | Citations (PDF) |
| 36 | A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma | 6.4 | 8 | Citations (PDF) |
| 37 | Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers | 14.1 | 23 | Citations (PDF) |
| 38 | Analyzing cell-type-specific dynamics of metabolism in kidney repair | 11.9 | 79 | Citations (PDF) |
| 39 | Metabolic Reprogramming in Tumor Endothelial Cells | 4.5 | 28 | Citations (PDF) |
| 40 | Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast | 14.1 | 65 | Citations (PDF) |
| 41 | HIF1A-dependent induction of alveolar epithelial PFKFB3 dampens acute lung injury | 5.5 | 12 | Citations (PDF) |
| 42 | Glutamine Metabolism in Osteoprogenitors Is Required for Bone Mass Accrual and PTH-Induced Bone Anabolism in Male Mice | 5.1 | 44 | Citations (PDF) |
| 43 | Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype | 7.7 | 18 | Citations (PDF) |
| 44 | Successful double-lung transplantation from a donor previously infected with SARS-CoV-2 | 22.1 | 41 | Citations (PDF) |
| 45 | Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and Glycogenesis | 26.3 | 109 | Citations (PDF) |
| 46 | Phenotypic diversity and metabolic specialization of renal endothelial cells | 13.6 | 73 | Citations (PDF) |
| 47 | Hypoxia-inducible factor–1α–dependent induction of miR122 enhances hepatic ischemia tolerance | 9.1 | 38 | Citations (PDF) |
| 48 | Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice | 3.7 | 3 | Citations (PDF) |
| 49 | Endothelial metabolism going single | 11.9 | 2 | Citations (PDF) |
| 50 | Endothelial cell plasticity at the single-cell level | 7.4 | 54 | Citations (PDF) |
| 51 | Endothelial Insulin Receptors Promote VEGF-A Signaling via ERK1/2 and Sprouting Angiogenesis | 2.7 | 22 | Citations (PDF) |
| 52 | High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity | 6.4 | 106 | Citations (PDF) |
| 53 | Protocols for endothelial cell isolation from mouse tissues: small intestine, colon, heart, and liver | 1.1 | 13 | Citations (PDF) |
| 54 | Tumor vessel co-option probed by single-cell analysis | 6.4 | 56 | Citations (PDF) |
| 55 | Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis | 3.7 | 8 | Citations (PDF) |
| 56 | Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension | 7.7 | 2 | Citations (PDF) |
| 57 | Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19 | 22.1 | 39 | Citations (PDF) |
| 58 | Hierarchical imaging and computational analysis of three-dimensional vascular network architecture in the entire postnatal and adult mouse brain | 14.6 | 33 | Citations (PDF) |
| 59 | Protocols for endothelial cell isolation from mouse tissues: kidney, spleen, and testis | 1.1 | 12 | Citations (PDF) |
| 60 | Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis | 26.3 | 36 | Citations (PDF) |
| 61 | Comparative meta-analysis of cystic fibrosis cell models suggests partial endothelial-to-mesenchymal transition | 0.8 | 5 | Citations (PDF) |
| 62 | Cardiac Microvascular Endothelial Cells in Pressure Overload–Induced Heart Disease | 4.8 | 22 | Citations (PDF) |
| 63 | Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis | 11.4 | 15 | Citations (PDF) |
| 64 | The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors | 4.0 | 16 | Citations (PDF) |
| 65 | Shear Stress Regulation of Endothelial Glycocalyx Structure Is Determined by Glucobiosynthesis | 6.2 | 81 | Citations (PDF) |
| 66 | Homeostasis and transitional activation of regulatory T cells require c-Myc | 11.3 | 60 | Citations (PDF) |
| 67 | Metabolic Signatures of Distinct Endothelial Phenotypes | 11.8 | 53 | Citations (PDF) |
| 68 | Heterogeneous Effects of Calorie Content and Nutritional Components Underlie Dietary Influence on Pancreatic Cancer Susceptibility | 6.4 | 6 | Citations (PDF) |
| 69 | c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis | 11.9 | 16 | Citations (PDF) |
| 70 | DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumor immunotolerance | 8.4 | 42 | Citations (PDF) |
| 71 | Macrophage-derived glutamine boosts satellite cells and muscle regeneration | 40.1 | 143 | Citations (PDF) |
| 72 | BIOMEX: an interactive workflow for (single cell) omics data interpretation and visualization | 16.2 | 45 | Citations (PDF) |
| 73 | Endothelial Lactate Controls Muscle Regeneration from Ischemia by Inducing M2-like Macrophage Polarization | 26.3 | 281 | Citations (PDF) |
| 74 | Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity | 12.8 | 124 | Citations (PDF) |
| 75 | Glutamine Metabolism Controls Chondrocyte Identity and Function | 7.8 | 73 | Citations (PDF) |
| 76 | COVID-19: the vasculature unleashed | 17.9 | 794 | Citations (PDF) |
| 77 | Lowering the increased intracellular pH of human-induced pluripotent stem cell-derived endothelial cells induces formation of mature Weibel-Palade bodies | 3.6 | 10 | Citations (PDF) |
| 78 | Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines | 14.1 | 82 | Citations (PDF) |
| 79 | Basic and Therapeutic Aspects of Angiogenesis Updated | 12.8 | 321 | Citations (PDF) |
| 80 | Lipid availability determines fate of skeletal progenitor cells via SOX9 | 40.1 | 159 | Citations (PDF) |
| 81 | Single-Cell Transcriptome Atlas of Murine Endothelial CellsCell, 2020, 180, 764-779.e20 | 35.1 | 776 | Citations (PDF) |
| 82 | An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates | 33.4 | 271 | Citations (PDF) |
| 83 | PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase | 14.1 | 171 | Citations (PDF) |
| 84 | Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis | 7.2 | 42 | Citations (PDF) |
| 85 | Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis | 26.3 | 194 | Citations (PDF) |
| 86 | Single-Cell RNA Sequencing Reveals Renal Endothelium Heterogeneity and Metabolic Adaptation to Water Deprivation | 0.4 | 131 | Citations (PDF) |
| 87 | Matrix deformations around angiogenic sprouts correlate to sprout dynamics and suggest pulling activity | 7.4 | 38 | Citations (PDF) |
| 88 | Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation | 26.3 | 86 | Citations (PDF) |
| 89 | Functional reprogramming of regulatory T cells in the absence of Foxp3 | 13.1 | 108 | Citations (PDF) |
| 90 | Myeloid Phd2 Knockdown Drives Macrophage Apoptosis And Paracrine Fibroblast/Smooth Muscle Cell Collagen Secretion Leading To Atherosclerotic Plaque Fibrosis | 1.2 | 0 | Citations (PDF) |
| 91 | Adult Pgf−/− mice behaviour and neuroanatomy are altered by neonatal treatment with recombinant placental growth factor | 3.7 | 10 | Citations (PDF) |
| 92 | Role and therapeutic potential of dietary ketone bodies in lymph vessel growth | 11.9 | 51 | Citations (PDF) |
| 93 | PKM2 regulates endothelial cell junction dynamics and angiogenesis via ATP production | 3.7 | 41 | Citations (PDF) |
| 94 | P021 CFTR loss of function leads to increased ROS and endothelial dysfunction | 0.8 | 0 | Citations (PDF) |
| 95 | Partial Inhibition Of The Key Glycolytic Enzyme Pfkfb3 In Myeloid Cells Impacts Whole-Body Immune Cell And Liver Metabolism, But Not Atherogenesis. | 1.2 | 1 | Citations (PDF) |
| 96 | Closing the Mitochondrial Permeability Transition Pore in hiPSC-Derived Endothelial Cells Induces Glycocalyx Formation and Functional Maturation | 4.7 | 17 | Citations (PDF) |
| 97 | Glomerular Function and Structural Integrity Depend on Hyaluronan Synthesis by Glomerular Endothelium | 0.4 | 53 | Citations (PDF) |
| 98 | Hallmarks of Endothelial Cell Metabolism in Health and Disease | 26.3 | 296 | Citations (PDF) |
| 99 | Differentiation but not ALS mutations in FUS rewires motor neuron metabolism | 14.1 | 38 | Citations (PDF) |
| 100 | Analysis of Endothelial Fatty Acid Metabolism Using Tracer Metabolomics | 0.0 | 2 | Citations (PDF) |
| 101 | Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPRCell, 2019, 177, 1201-1216.e19 | 35.1 | 105 | Citations (PDF) |
| 102 | IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses <i>In Vivo</i> | 9.7 | 39 | Citations (PDF) |
| 103 | Metabolic Pathways Fueling the Endothelial Cell Drive | 17.9 | 110 | Citations (PDF) |
| 104 | Un nouveau rôle non métabolique de la glutamine synthétase au cours de l’angiogenèse | 0.2 | 0 | Citations (PDF) |
| 105 | The metabolic engine of endothelial cells | 11.9 | 89 | Citations (PDF) |
| 106 | Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism | 2.4 | 68 | Citations (PDF) |
| 107 | HIF-1α metabolically controls collagen synthesis and modification in chondrocytes | 40.1 | 195 | Citations (PDF) |
| 108 | EndoDB: a database of endothelial cell transcriptomics data | 16.2 | 68 | Citations (PDF) |
| 109 | How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development | 1.9 | 49 | Citations (PDF) |
| 110 | Metabolic Reprogramming during Microglia Activation | 2.8 | 23 | Citations (PDF) |
| 111 | Blockade of Myeloid-Derived Suppressor Cell Expansion with All-<i>Trans</i> Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy | 0.6 | 92 | Citations (PDF) |
| 112 | Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation | 14.1 | 106 | Citations (PDF) |
| 113 | The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression | 6.4 | 117 | Citations (PDF) |
| 114 | Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging | 17.2 | 276 | Citations (PDF) |
| 115 | Endothelial Cell Metabolism | 26.6 | 384 | Citations (PDF) |
| 116 | Endothelial Cell Metabolism in Health and Disease | 15.3 | 223 | Citations (PDF) |
| 117 | Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice | 9.1 | 41 | Citations (PDF) |
| 118 | Gas6 is dispensable for pubertal mammary gland development | 2.5 | 10 | Citations (PDF) |
| 119 | Role of glutamine synthetase in angiogenesis beyond glutamine synthesis | 40.1 | 147 | Citations (PDF) |
| 120 | Consensus guidelines for the use and interpretation of angiogenesis assays | 7.4 | 445 | Citations (PDF) |
| 121 | Defective endothelial cell migration in the absence of Cdc42 leads to capillary-venous malformations | 3.0 | 45 | Citations (PDF) |
| 122 | Live imaging reveals a conserved role of fatty acid β-oxidation in early lymphatic development in zebrafish | 2.1 | 3 | Citations (PDF) |
| 123 | Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin | 14.1 | 98 | Citations (PDF) |
| 124 | Phenotype molding of stromal cells in the lung tumor microenvironment | 25.6 | 1,082 | Citations (PDF) |
| 125 | Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells | 26.3 | 135 | Citations (PDF) |
| 126 | Emerging Concepts in Organ-Specific Lymphatic Vessels and Metabolic Regulation of Lymphatic Development | 7.8 | 54 | Citations (PDF) |
| 127 | Effects of placental growth factor deficiency on behavior, neuroanatomy, and cerebrovasculature of mice | 2.5 | 21 | Citations (PDF) |
| 128 | Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis | 26.3 | 188 | Citations (PDF) |
| 129 | Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation | 26.3 | 174 | Citations (PDF) |
| 130 | CPT1a-Dependent Long-Chain Fatty Acid Oxidation Contributes to Maintaining Glucagon Secretion from Pancreatic Islets | 6.4 | 70 | Citations (PDF) |
| 131 | Stromal Gas6 promotes the progression of premalignant mammary cells | 6.6 | 27 | Citations (PDF) |
| 132 | Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid LeukemiaBlood, 2018, 132, 759-759 | 1.0 | 0 | Citations (PDF) |
| 133 | 826: PlGF deficiency results in sFlt-1 elevation without the onset of preeclampsia in pregnant mice | 2.5 | 0 | Citations (PDF) |
| 134 | Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective | 2.1 | 42 | Citations (PDF) |
| 135 | Vessel pruning or healing: endothelial metabolism as a novel target? | 3.9 | 44 | Citations (PDF) |
| 136 | The ER Stress Sensor PERK Coordinates ER-Plasma Membrane Contact Site Formation through Interaction with Filamin-A and F-Actin Remodeling | 14.2 | 168 | Citations (PDF) |
| 137 | Interaction of endothelial cells with macrophages—linking molecular and metabolic signaling | 2.4 | 41 | Citations (PDF) |
| 138 | Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity | 14.1 | 76 | Citations (PDF) |
| 139 | Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism | 14.0 | 65 | Citations (PDF) |
| 140 | Endothelial cell metabolism: an update anno 2017 | 3.0 | 35 | Citations (PDF) |
| 141 | FGF-dependent metabolic control of vascular development | 40.1 | 271 | Citations (PDF) |
| 142 | How to Cross the Lymphatic Fence | 12.8 | 3 | Citations (PDF) |
| 143 | Vascular Endothelial Growth Factor Up-regulation in Human Amniotic Fluid Stem Cell Enhances Nephroprotection After Ischemia-Reperfusion Injury in the Rat | 0.6 | 23 | Citations (PDF) |
| 144 | DOT1L safeguards cartilage homeostasis and protects against osteoarthritis | 14.1 | 104 | Citations (PDF) |
| 145 | Endothelial cell metabolism in health and disease: impact of hypoxia | 7.4 | 189 | Citations (PDF) |
| 146 | Therapeutic Potential of Allosteric Modulation of FGF Receptors 2017, , 169-185 | | 0 | Citations (PDF) |
| 147 | Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction | 19.4 | 58 | Citations (PDF) |
| 148 | CLARITY reveals dynamics of ovarian follicular architecture and vasculature in three-dimensions | 3.7 | 66 | Citations (PDF) |
| 149 | Central Role of Metabolism in Endothelial Cell Function and Vascular Disease | 5.5 | 69 | Citations (PDF) |
| 150 | Myocardial Infarction Primes Autoreactive T Cells through Activation of Dendritic Cells | 6.4 | 99 | Citations (PDF) |
| 151 | Haematopoietic prolyl hydroxylase‐1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis | 5.2 | 32 | Citations (PDF) |
| 152 | The Link Between Angiogenesis and Endothelial Metabolism | 17.9 | 259 | Citations (PDF) |
| 153 | Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2 | 19.4 | 194 | Citations (PDF) |
| 154 | PP2A Inactivation Mediated by <i>PPP2R4</i> Haploinsufficiency Promotes Cancer Development | 0.6 | 33 | Citations (PDF) |
| 155 | A Fatty Acid Oxidation-Dependent Metabolic Shift Regulates Adult Neural Stem Cell Activity | 6.4 | 233 | Citations (PDF) |
| 156 | Tumor vessel disintegration by maximum tolerable PFKFB3 blockade | 7.4 | 70 | Citations (PDF) |
| 157 | Opposing regulation and roles for PHD3 in lung dendritic cells and alveolar macrophages | 3.0 | 7 | Citations (PDF) |
| 158 | Early ciliary and prominin-1 dysfunctions precede neurogenesis impairment in a mouse model of type 2 diabetes | 5.2 | 13 | Citations (PDF) |
| 159 | Influences of placental growth factor on mouse retinal vascular development | 1.7 | 10 | Citations (PDF) |
| 160 | Role of glutamine and interlinked asparagine metabolism in vessel formation | 7.4 | 222 | Citations (PDF) |
| 161 | Nogo-A regulates vascular network architecture in the postnatal brain | 4.9 | 17 | Citations (PDF) |
| 162 | Neurogenic Radial Glia-like Cells in Meninges Migrate and Differentiate into Functionally Integrated Neurons in the Neonatal Cortex | 17.2 | 61 | Citations (PDF) |
| 163 | Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia | 6.4 | 33 | Citations (PDF) |
| 164 | Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism | 3.4 | 95 | Citations (PDF) |
| 165 | How Endothelial Cells Adapt Their Metabolism to Form Vessels in Tumors | 5.0 | 86 | Citations (PDF) |
| 166 | A hypoxia response element in the Vegfa promoter is required for basal Vegfa expression in skin and for optimal granulation tissue formation during wound healing in mice | 2.5 | 22 | Citations (PDF) |
| 167 | Glycolytic adaptation and progression of kidney disease | 13.6 | 15 | Citations (PDF) |
| 168 | Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses | 9.1 | 73 | Citations (PDF) |
| 169 | Author Response: Possibility of Cytoplasmic Transportation Between Donor–Host Cell Following Photoreceptor Transplantation 2016, 57, 5336 | | 0 | Citations (PDF) |
| 170 | Stem Cell–Derived Photoreceptor Transplants Differentially Integrate Into Mouse Models of Cone-Rod Dystrophy 2016, 57, 3509 | | 71 | Citations (PDF) |
| 171 | Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers—A New Perspective? | 16.4 | 42 | Citations (PDF) |
| 172 | Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis | 7.4 | 151 | Citations (PDF) |
| 173 | Meta‐analysis of clinical metabolic profiling studies in cancer: challenges and opportunities | 7.2 | 87 | Citations (PDF) |
| 174 | Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner | 2.1 | 28 | Citations (PDF) |
| 175 | Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia | 2.2 | 42 | Citations (PDF) |
| 176 | Improved metabolite identification with MIDAS and MAGMa through MS/MS spectral dataset-driven parameter optimization | 2.8 | 36 | Citations (PDF) |
| 177 | Adequate hypoxia inducible factor 1α signaling is indispensable for bone regeneration | 3.5 | 40 | Citations (PDF) |
| 178 | Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expressionBlood, 2016, 127, 2641-2644 | 1.0 | 24 | Citations (PDF) |
| 179 | Endothelial cell metabolism: A novel player in atherosclerosis? Basic principles and therapeutic opportunities | 1.2 | 64 | Citations (PDF) |
| 180 | Tumour hypoxia causes DNA hypermethylation by reducing TET activity | 40.1 | 483 | Citations (PDF) |
| 181 | Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy | 33.4 | 485 | Citations (PDF) |
| 182 | De novo design of a biologically active amyloid | 38.2 | 60 | Citations (PDF) |
| 183 | Glycolytic regulation of cell rearrangement in angiogenesis | 14.1 | 130 | Citations (PDF) |
| 184 | Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis | 26.3 | 379 | Citations (PDF) |
| 185 | S84 Identification of MIR-124a as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension | 4.8 | 2 | Citations (PDF) |
| 186 | Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma | 3.0 | 26 | Citations (PDF) |
| 187 | Gas6 protein: its role in cardiovascular calcification | 2.2 | 18 | Citations (PDF) |
| 188 | Placental growth factor deficiency is associated with impaired cerebral vascular development in mice | 2.9 | 56 | Citations (PDF) |
| 189 | Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice | 1.5 | 19 | Citations (PDF) |
| 190 | The Oxygen Sensor PHD2 Controls Dendritic Spines and Synapses via Modification of Filamin A | 6.4 | 47 | Citations (PDF) |
| 191 | PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity | 6.4 | 110 | Citations (PDF) |
| 192 | HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival | 26.3 | 149 | Citations (PDF) |
| 193 | Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature | 2.0 | 20 | Citations (PDF) |
| 194 | Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism | 26.3 | 77 | Citations (PDF) |
| 195 | Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome | 1.0 | 284 | Citations (PDF) |
| 196 | FOXO1 couples metabolic activity and growth state in the vascular endothelium | 40.1 | 424 | Citations (PDF) |
| 197 | Targeting fatty acid metabolism in cancer and endothelial cells | 5.3 | 68 | Citations (PDF) |
| 198 | The role of fatty acid β-oxidation in lymphangiogenesis | 40.1 | 246 | Citations (PDF) |
| 199 | Vascular endothelial growth factor: a neurovascular target in neurological diseases | 9.2 | 264 | Citations (PDF) |
| 200 | Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13 | 9.1 | 32 | Citations (PDF) |
| 201 | A key role for transketolase-like 1 in tumor metabolic reprogramming | 1.7 | 45 | Citations (PDF) |
| 202 | Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow | 1.7 | 28 | Citations (PDF) |
| 203 | Abstract IA06: Angiogenesis revisited: Role and (therapeutic) implications of endothelial metabolism 2016, , | | 0 | Citations (PDF) |
| 204 | Corrigendum to “Impact of placental growth factor deficiency on early mouse implant site angiogenesis” [Placenta 35 (2014) 772–775] | 1.1 | 0 | Citations (PDF) |
| 205 | P0290 : Placental growth factor inhibition modulates the interplay between hypoxia and the unfolded protein response in hepatocellular carcinoma | 2.9 | 0 | Citations (PDF) |
| 206 | Metabolic Adaptations in Diabetic Endothelial Cells | 1.8 | 38 | Citations (PDF) |
| 207 | Angiogenesis revisited: Endothelial cell metabolism as a target? | 0.4 | 0 | Citations (PDF) |
| 208 | Highly proliferative primitive fetal liver hematopoietic stem cells are fueled by oxidative metabolic pathways | 0.6 | 62 | Citations (PDF) |
| 209 | Endothelial cells and cancer cells | 3.0 | 18 | Citations (PDF) |
| 210 | Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting | 1.7 | 98 | Citations (PDF) |
| 211 | Endothelial Metabolism Driving Angiogenesis | 1.9 | 25 | Citations (PDF) |
| 212 | The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis | 5.5 | 47 | Citations (PDF) |
| 213 | Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways | 6.4 | 210 | Citations (PDF) |
| 214 | Meox2/Tcf15 Heterodimers Program the Heart Capillary Endothelium for Cardiac Fatty Acid Uptake | 19.4 | 84 | Citations (PDF) |
| 215 | Placental Growth Factor Influences Maternal Cardiovascular Adaptation to Pregnancy in Mice1 | 2.7 | 26 | Citations (PDF) |
| 216 | The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts | 6.4 | 66 | Citations (PDF) |
| 217 | State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization | 12.8 | 103 | Citations (PDF) |
| 218 | Targeting endothelial cell metabolism: new therapeutic prospects? | 0.9 | 2 | Citations (PDF) |
| 219 | Fatty acid carbon is essential for dNTP synthesis in endothelial cells | 40.1 | 483 | Citations (PDF) |
| 220 | Endothelial Cell Metabolism in Normal and Diseased Vasculature | 12.8 | 464 | Citations (PDF) |
| 221 | Extra-intestinal calcium handling contributes to normal serum calcium levels when intestinal calcium absorption is suboptimal | 3.5 | 16 | Citations (PDF) |
| 222 | Metabolic control of the cell cycle | 3.2 | 75 | Citations (PDF) |
| 223 | Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds | 3.7 | 119 | Citations (PDF) |
| 224 | Metabolic pathway compartmentalization: an underappreciated opportunity? | 7.6 | 64 | Citations (PDF) |
| 225 | Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1α independent proliferation | 3.6 | 61 | Citations (PDF) |
| 226 | Deletion of Placental Growth Factor Prevents Diabetic Retinopathy and Is Associated With Akt Activation and HIF1α-VEGF Pathway Inhibition | 0.5 | 117 | Citations (PDF) |
| 227 | Essentials of Angiogenesis 2015, , 137-165 | | 1 | Citations (PDF) |
| 228 | The PHD2 oxygen sensor paves the way to metastasis | 1.7 | 8 | Citations (PDF) |
| 229 | Abstract SY15-04: Angiogenesis revisited: Endothelial cell metabolism as a target 2015, , | | 0 | Citations (PDF) |
| 230 | Placenta Growth Factor Links the IL-13 Response and the Leukotriene Pathway to Augment Airway Hyper-ResponsivenessBlood, 2015, 126, 977-977 | 1.0 | 0 | Citations (PDF) |
| 231 | BGB324 Inhibits BCR-ABL TKI-Resistant Chronic Myeloid LeukemiaBlood, 2015, 126, 1569-1569 | 1.0 | 0 | Citations (PDF) |
| 232 | Endothelial cell metabolism: parallels and divergences with cancer cell metabolism | 4.8 | 96 | Citations (PDF) |
| 233 | How to teach an old dog new tricks: Autophagy-independent action of chloroquine on the tumor vasculature | 13.8 | 17 | Citations (PDF) |
| 234 | Placental growth factor in cancer | 3.9 | 57 | Citations (PDF) |
| 235 | Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR | 14.1 | 59 | Citations (PDF) |
| 236 | Age-Dependent Neonatal Intracerebral Hemorrhage in Plasminogen Activator Inhibitor 1 Knockout Mice | 1.9 | 12 | Citations (PDF) |
| 237 | S138 Nanodiamond Delivery Of Vascular Endothelial Growth Factor Promotes Fetal Lung Development In A Rat Model Of Congenital Diaphragmatic Hernia | 4.8 | 1 | Citations (PDF) |
| 238 | Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? | 1.5 | 74 | Citations (PDF) |
| 239 | Endothelial Cell Differentiation by SOX17 | 12.8 | 12 | Citations (PDF) |
| 240 | Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy | 7.4 | 39 | Citations (PDF) |
| 241 | Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential | 7.4 | 13 | Citations (PDF) |
| 242 | Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis | 26.3 | 434 | Citations (PDF) |
| 243 | Genetic markers of bevacizumab-induced hypertension | 7.4 | 23 | Citations (PDF) |
| 244 | Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism | 6.4 | 99 | Citations (PDF) |
| 245 | Vascular endothelial growth factor‐loaded injectable hydrogel enhances plasticity in the injured spinal cord | 4.3 | 51 | Citations (PDF) |
| 246 | Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population | 0.6 | 345 | Citations (PDF) |
| 247 | Allosteric targeting of receptor tyrosine kinases | 18.1 | 76 | Citations (PDF) |
| 248 | HIF1 Activity in Granulosa Cells Is Required for FSH-Regulated Vegfa Expression and Follicle Survival in Mice1 | 2.7 | 39 | Citations (PDF) |
| 249 | Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease | 7.2 | 153 | Citations (PDF) |
| 250 | Fibroblast Growth Factor Signaling Affects Vascular Outgrowth and Is Required for the Maintenance of Blood Vessel Integrity | 5.3 | 35 | Citations (PDF) |
| 251 | The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses | 10.5 | 118 | Citations (PDF) |
| 252 | Angiogenesis revisited – role and therapeutic potential of targeting endothelial metabolism | 3.2 | 63 | Citations (PDF) |
| 253 | Tumor Vessel Normalization by Chloroquine Independent of Autophagy | 33.4 | 354 | Citations (PDF) |
| 254 | Tissue plasminogen activator arrests Alzheimer's disease pathogenesis | 3.4 | 39 | Citations (PDF) |
| 255 | PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin | 25.6 | 77 | Citations (PDF) |
| 256 | Metabolism of stromal and immune cells in health and disease | 40.1 | 366 | Citations (PDF) |
| 257 | Bevacizumab and micrometastases: Revisiting the preclinical and clinical rollercoaster 2014, 141, 117-124 | | 38 | Citations (PDF) |
| 258 | P477Myeloid PHD-2 deficiency leads to enlarged and fibrotic atherosclerotic plaques in mice | 5.6 | 0 | Citations (PDF) |
| 259 | 13PHD1 deficiency promotes an atheroprotective metabolic phenotype | 5.6 | 0 | Citations (PDF) |
| 260 | Essentials of Angiogenesis 2014, , 1-34 | | 0 | Citations (PDF) |
| 261 | Abstract IA17: Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma 2014, , | | 0 | Citations (PDF) |
| 262 | BGB324 Represents an Axl and BCR-ABL1 Inhibitor with Activity in the T315I MutantBlood, 2014, 124, 4512-4512 | 1.0 | 1 | Citations (PDF) |
| 263 | Role of PFKFB3-Driven Glycolysis in Vessel Sprouting | 35.1 | 1,130 | Citations (PDF) |
| 264 | The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model | 2.9 | 22 | Citations (PDF) |
| 265 | Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection | 2.2 | 25 | Citations (PDF) |
| 266 | PP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7 | 7.4 | 40 | Citations (PDF) |
| 267 | Role of Endothelial Cell Metabolism in Vessel Sprouting | 26.3 | 316 | Citations (PDF) |
| 268 | Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning | 2.0 | 53 | Citations (PDF) |
| 269 | Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation | 5.2 | 41 | Citations (PDF) |
| 270 | Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation Through a Placental Growth Factor‐Dependent Mechanism | 4.3 | 89 | Citations (PDF) |
| 271 | Markers of Response for the Antiangiogenic Agent Bevacizumab | 17.1 | 287 | Citations (PDF) |
| 272 | Prominin-1 Allows Prospective Isolation of Neural Stem Cells from the Adult Murine Hippocampus | 3.7 | 59 | Citations (PDF) |
| 273 | High t-PA release by neonate brain microvascular endothelial cells under glutamate exposure affects neuronal fate | 5.2 | 22 | Citations (PDF) |
| 274 | Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stromaBlood, 2013, 122, 2443-2452 | 1.0 | 176 | Citations (PDF) |
| 275 | HIF-1α stabilization in Phd1/3-/- mice results in increase in hematopoietic stem cell number and enhanced HSC maintenance in BM niche | 0.4 | 1 | Citations (PDF) |
| 276 | CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells | 0.4 | 0 | Citations (PDF) |
| 277 | Control of vessel sprouting by genetic and metabolic determinants | 11.8 | 52 | Citations (PDF) |
| 278 | VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration | 5.6 | 140 | Citations (PDF) |
| 279 | Tanycytic VEGF-A Boosts Blood-Hypothalamus Barrier Plasticity and Access of Metabolic Signals to the Arcuate Nucleus in Response to Fasting | 26.3 | 277 | Citations (PDF) |
| 280 | Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of MedulloblastomaCell, 2013, 152, 1065-1076 | 35.1 | 200 | Citations (PDF) |
| 281 | Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties | 33.4 | 134 | Citations (PDF) |
| 282 | Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling | 33.4 | 114 | Citations (PDF) |
| 283 | Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium | 9.1 | 65 | Citations (PDF) |
| 284 | Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes | 8.1 | 124 | Citations (PDF) |
| 285 | A transgenic <i>Xenopus laevis</i> reporter model to study lymphangiogenesis | 1.5 | 10 | Citations (PDF) |
| 286 | Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis | 4.5 | 76 | Citations (PDF) |
| 287 | CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells | 7.7 | 43 | Citations (PDF) |
| 288 | Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis | 4.8 | 1 | Citations (PDF) |
| 289 | The NADPH oxidase Nox2 regulates VEGFR1/CSF‐1R‐mediated microglial chemotaxis and promotes early postnatal infiltration of phagocytes in the subventricular zone of the mouse cerebral cortexGlia, 2013, 61, 1542-1555 | 5.2 | 43 | Citations (PDF) |
| 290 | The Fragile X Protein binds m
<scp>RNA</scp>
s involved in cancer progression and modulates metastasis formation | 7.2 | 109 | Citations (PDF) |
| 291 | Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models | 11.6 | 83 | Citations (PDF) |
| 292 | Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer | 9.1 | 495 | Citations (PDF) |
| 293 | Hypoxia-Ischemia or Excitotoxin-Induced Tissue Plasminogen Activator- Dependent Gelatinase Activation in Mice Neonate Brain Microvessels | 2.5 | 15 | Citations (PDF) |
| 294 | PAR1 contributes to influenza A virus pathogenicity in mice | 9.1 | 74 | Citations (PDF) |
| 295 | Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin Resistance | 2.5 | 57 | Citations (PDF) |
| 296 | Axl Represents a Therapeutic Target In T315I-Mutated and WT Chronic Myeloid LeukemiaBlood, 2013, 122, 1469-1469 | 1.0 | 0 | Citations (PDF) |
| 297 | Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis | 4.8 | 30 | Citations (PDF) |
| 298 | MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis | 12.8 | 187 | Citations (PDF) |
| 299 | Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers | 1.9 | 11 | Citations (PDF) |
| 300 | PIGF Knockout Delays Brain Vessel Growth and Maturation upon Systemic Hypoxic Challenge | 4.9 | 32 | Citations (PDF) |
| 301 | MOSAIC: A Multiscale Model of Osteogenesis and Sprouting Angiogenesis with Lateral Inhibition of Endothelial Cells | 3.3 | 67 | Citations (PDF) |
| 302 | Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin | 7.7 | 39 | Citations (PDF) |
| 303 | Placental Growth Factor Contributes to Bronchial Neutrophilic Inflammation and Edema in Allergic Asthma | 3.9 | 20 | Citations (PDF) |
| 304 | Engineering Vascularized Bone: Osteogenic and Proangiogenic Potential of Murine Periosteal Cells | 3.3 | 93 | Citations (PDF) |
| 305 | Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model | 1.4 | 12 | Citations (PDF) |
| 306 | Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenaseBlood, 2012, 119, 5048-5056 | 1.0 | 80 | Citations (PDF) |
| 307 | A breach in the blood–brain barrier | 40.1 | 22 | Citations (PDF) |
| 308 | VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials | 21.9 | 156 | Citations (PDF) |
| 309 | 328 Role of the Fragile X Mental Retardation Protein in Tumor Progression and Metastasis Formation | 3.3 | 0 | Citations (PDF) |
| 310 | Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells | 5.6 | 56 | Citations (PDF) |
| 311 | Peroxisome deficient aP2–Pex5 knockout mice display impaired white adipocyte and muscle function concomitant with reduced adrenergic tone | 0.9 | 18 | Citations (PDF) |
| 312 | Loss of the Oxygen Sensor PHD3 Enhances the Innate Immune Response to Abdominal Sepsis | 0.6 | 71 | Citations (PDF) |
| 313 | Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathyBrain, 2012, 135, 2629-2641 | 8.9 | 47 | Citations (PDF) |
| 314 | Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice | 2.9 | 21 | Citations (PDF) |
| 315 | SnapShot: Tumor AngiogenesisCell, 2012, 149, 1408-1408.e1 | 35.1 | 108 | Citations (PDF) |
| 316 | Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity | 33.4 | 112 | Citations (PDF) |
| 317 | Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment | 7.2 | 52 | Citations (PDF) |
| 318 | PlGF: A Multitasking Cytokine with Disease-Restricted Activity | 6.7 | 176 | Citations (PDF) |
| 319 | VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures | 2.5 | 20 | Citations (PDF) |
| 320 | Neuroprotection by urokinase plasminogen activator in the hippocampus | 5.2 | 29 | Citations (PDF) |
| 321 | Angiogenesis and the neurovascular link | 2.1 | 0 | Citations (PDF) |
| 322 | Absence of microRNA‐155 protects against pressure overload‐induced cardiac inflammation and failure | 0.7 | 0 | Citations (PDF) |
| 323 | Placental Growth Factor Regulates Cardiac Adaptation and Hypertrophy Through a Paracrine Mechanism | 12.8 | 77 | Citations (PDF) |
| 324 | TRPA1 underlies a sensing mechanism for O2 | 7.3 | 233 | Citations (PDF) |
| 325 | A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours | 40.1 | 398 | Citations (PDF) |
| 326 | Basic and Therapeutic Aspects of Angiogenesis | 35.1 | 2,211 | Citations (PDF) |
| 327 | Vessel abnormalization: another hallmark of cancer?Molecular mechanisms and therapeutic implications | 3.4 | 175 | Citations (PDF) |
| 328 | Transcription factor COUP-TFII is indispensable for venous and lymphatic development in zebrafish and Xenopus laevis | 2.1 | 42 | Citations (PDF) |
| 329 | Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy | 2.0 | 42 | Citations (PDF) |
| 330 | VEGF Mediates Commissural Axon Chemoattraction through Its Receptor Flk1 | 12.8 | 121 | Citations (PDF) |
| 331 | The Neurovascular Link in Health and Disease: Molecular Mechanisms and Therapeutic Implications | 12.8 | 215 | Citations (PDF) |
| 332 | 804 ORAL Evaluation of Plasma VEGFA as a Potential Predictive Pan-tumour Biomarker for Bevacizumab | 3.3 | 29 | Citations (PDF) |
| 333 | 1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension | 3.3 | 1 | Citations (PDF) |
| 334 | 1414 POSTER Single Nucleotide Polymorphism Analysis and Outcome in Advanced-stage Cancer Patients Treated With Bevacizumab | 3.3 | 9 | Citations (PDF) |
| 335 | Hypoxia and Inflammation | 25.5 | 1,649 | Citations (PDF) |
| 336 | Prolyl Hydroxylase Phd3 Is Essential For Hypoxic Regulation Of Neutrophilic Inflammation 2011, , A4009-A4009 | | 0 | Citations (PDF) |
| 337 | Reduced Retinal Neovascularization, Vascular Permeability, and Apoptosis in Ischemic Retinopathy in the Absence of Prolyl Hydroxylase-1 Due to the Prevention of Hyperoxia-Induced Vascular Obliteration 2011, 52, 7565 | | 35 | Citations (PDF) |
| 338 | Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic nicheBlood, 2011, 118, 1534-1543 | 1.0 | 66 | Citations (PDF) |
| 339 | Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases | 39.3 | 1,312 | Citations (PDF) |
| 340 | Molecular mechanisms and clinical applications of angiogenesis | 40.1 | 4,247 | Citations (PDF) |
| 341 | Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties | 4.1 | 46 | Citations (PDF) |
| 342 | 3D systems delivering VEGF to promote angiogenesis for tissue engineering | 11.3 | 116 | Citations (PDF) |
| 343 | HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF | 33.4 | 607 | Citations (PDF) |
| 344 | Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia | 33.4 | 119 | Citations (PDF) |
| 345 | Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling | 33.4 | 495 | Citations (PDF) |
| 346 | Cerebrovascular disorders: molecular insights and therapeutic opportunities | 12.4 | 73 | Citations (PDF) |
| 347 | FAF1, a Gene that Is Disrupted in Cleft Palate and Has Conserved Function in Zebrafish | 6.8 | 50 | Citations (PDF) |
| 348 | Involvement of placental growth factor in Wallerian degeneration | 5.2 | 31 | Citations (PDF) |
| 349 | Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice | 11.6 | 77 | Citations (PDF) |
| 350 | Stem cell marker prominin‐1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland | 1.7 | 26 | Citations (PDF) |
| 351 | Neuronal FLT1 receptor and its selective ligand VEGF‐B protect against retrograde degeneration of sensory neurons | 0.7 | 44 | Citations (PDF) |
| 352 | Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models | 6.2 | 90 | Citations (PDF) |
| 353 | Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next? | 17.1 | 141 | Citations (PDF) |
| 354 | Differential Endothelial Transcriptomics Identifies Semaphorin 3G as a Vascular Class 3 Semaphorin | 6.2 | 59 | Citations (PDF) |
| 355 | Notch3 Arg170Cys Knock-In Mice Display Pathologic and Clinical Features of the Neurovascular Disorder Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy | 6.2 | 39 | Citations (PDF) |
| 356 | VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation | 7.7 | 36 | Citations (PDF) |
| 357 | Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? | 25.3 | 242 | Citations (PDF) |
| 358 | Carbohydrate Metabolism Is Perturbed in Peroxisome-deficient Hepatocytes Due to Mitochondrial Dysfunction, AMP-activated Protein Kinase (AMPK) Activation, and Peroxisome Proliferator-activated Receptor γ Coactivator 1α (PGC-1α) Suppression | 2.3 | 39 | Citations (PDF) |
| 359 | Angiogenesis: A Target in Solid Tumors, Also in Leukemia? | 3.0 | 63 | Citations (PDF) |
| 360 | Transient reduction of placental angiogenesis in PAI-1-deficient mice | 2.5 | 14 | Citations (PDF) |
| 361 | Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice | 9.1 | 146 | Citations (PDF) |
| 362 | PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors | 2.5 | 52 | Citations (PDF) |
| 363 | Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host diseaseBlood, 2010, 115, 3390-3397 | 1.0 | 11 | Citations (PDF) |
| 364 | Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6Blood, 2010, 115, 2264-2273 | 1.0 | 141 | Citations (PDF) |
| 365 | Role of synectin in lymphatic development in zebrafish and frogsBlood, 2010, 116, 3356-3366 | 1.0 | 33 | Citations (PDF) |
| 366 | Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFδ/δ mouse model of amyotrophic lateral sclerosis | 3.2 | 35 | Citations (PDF) |
| 367 | Increased skeletal VEGF enhances β-catenin activity and results in excessively ossified bones | 7.4 | 176 | Citations (PDF) |
| 368 | Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury | 3.5 | 34 | Citations (PDF) |
| 369 | Bridges that guide and unite | 40.1 | 90 | Citations (PDF) |
| 370 | Role of Delta-like-4/Notch in the Formation and Wiring of the Lymphatic Network in Zebrafish | 6.2 | 101 | Citations (PDF) |
| 371 | Fumarase tumor suppressor gene and<i>MET</i>oncogene cooperate in upholding transformation and tumorigenesis | 0.7 | 10 | Citations (PDF) |
| 372 | Matrix-Binding Vascular Endothelial Growth Factor (VEGF) Isoforms Guide Granule Cell Migration in the Cerebellum via VEGF Receptor Flk1 | 3.7 | 72 | Citations (PDF) |
| 373 | Impaired Autonomic Regulation of Resistance Arteries in Mice With Low Vascular Endothelial Growth Factor or Upon Vascular Endothelial Growth Factor Trap Delivery | 19.4 | 37 | Citations (PDF) |
| 374 | Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development | 4.8 | 35 | Citations (PDF) |
| 375 | Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours | 14.8 | 65 | Citations (PDF) |
| 376 | From Vessel Sprouting to Normalization | 6.2 | 60 | Citations (PDF) |
| 377 | NuSAP is essential for chromatin-induced spindle formation during early embryogenesis | 3.2 | 55 | Citations (PDF) |
| 378 | Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation | 19.4 | 121 | Citations (PDF) |
| 379 | Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3 | 5.6 | 60 | Citations (PDF) |
| 380 | Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions | 5.6 | 52 | Citations (PDF) |
| 381 | Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors | 5.6 | 36 | Citations (PDF) |
| 382 | Anti–Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation | 0.6 | 44 | Citations (PDF) |
| 383 | Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration | 0.0 | 21 | Citations (PDF) |
| 384 | Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability | 0.8 | 46 | Citations (PDF) |
| 385 | 165 JNJ-26483327, a second-generation spectrum-targeted protein tyrosine kinase inhibitor with superior characteristics in advanced cancer models | 0.5 | 0 | Citations (PDF) |
| 386 | Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury | 1.0 | 107 | Citations (PDF) |
| 387 | Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function | 1.0 | 179 | Citations (PDF) |
| 388 | Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug Candidates | 3.8 | 212 | Citations (PDF) |
| 389 | VEGF Receptor 2 Endocytic Trafficking Regulates Arterial Morphogenesis | 7.8 | 203 | Citations (PDF) |
| 390 | Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease | 35.1 | 230 | Citations (PDF) |
| 391 | Epithelial: Endothelial cross-talk regulates exocrine differentiation in developing pancreas | 1.9 | 67 | Citations (PDF) |
| 392 | Placental growth factor mediates aldosterone-dependent vascular injury in mice | 9.1 | 60 | Citations (PDF) |
| 393 | NuSAP is essential for chromatin-induced spindle formation during early embryogenesis | 3.0 | 0 | Citations (PDF) |
| 394 | Variants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration | 3.1 | 483 | Citations (PDF) |
| 395 | Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms | 19.4 | 157 | Citations (PDF) |
| 396 | “Antimyeloangiogenic” Therapy for Cancer by Inhibiting PlGF | 6.4 | 58 | Citations (PDF) |
| 397 | Growth Arrest Specific Protein 6 Participates in DOCA-Induced Target-Organ Damage | 7.0 | 13 | Citations (PDF) |
| 398 | Loss of the Cholesterol-Binding Protein Prominin-1/CD133 Causes Disk Dysmorphogenesis and Photoreceptor Degeneration | 3.7 | 153 | Citations (PDF) |
| 399 | G Protein-Coupled Receptor APJ and Its Ligand Apelin Act Downstream of Cripto to Specify Embryonic Stem Cells Toward the Cardiac Lineage Through Extracellular Signal-Regulated Kinase/p70S6 Kinase Signaling Pathway | 12.8 | 80 | Citations (PDF) |
| 400 | Plasminogen Activator Inhibitor-1 Regulates Integrin αvβ3 Expression and Autocrine Transforming Growth Factor β Signaling | 2.3 | 28 | Citations (PDF) |
| 401 | Mechanisms of Vessel Branching | 6.2 | 311 | Citations (PDF) |
| 402 | Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration | 2.1 | 68 | Citations (PDF) |
| 403 | Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells | 9.1 | 51 | Citations (PDF) |
| 404 | Food‐restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve | 8.2 | 10 | Citations (PDF) |
| 405 | Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction | 8.1 | 178 | Citations (PDF) |
| 406 | Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy | 19.4 | 89 | Citations (PDF) |
| 407 | Fibrinolysis‐independent role of plasmin and its activators in the haematopoietic recovery after myeloablation | 4.1 | 20 | Citations (PDF) |
| 408 | Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited | 33.4 | 329 | Citations (PDF) |
| 409 | Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells | 3.6 | 32 | Citations (PDF) |
| 410 | VEGF‐D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis | 5.2 | 35 | Citations (PDF) |
| 411 | Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way | 25.3 | 172 | Citations (PDF) |
| 412 | Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease | 39.3 | 291 | Citations (PDF) |
| 413 | Role and Therapeutic Potential of VEGF in the Nervous System | 26.6 | 370 | Citations (PDF) |
| 414 | Regulation of Angiogenesis by Oxygen and Metabolism | 7.8 | 338 | Citations (PDF) |
| 415 | Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization | 35.1 | 682 | Citations (PDF) |
| 416 | Oxygen Sensors at the Crossroad of Metabolism | 26.3 | 241 | Citations (PDF) |
| 417 | The neurovascular link in health and disease: an update | 10.0 | 61 | Citations (PDF) |
| 418 | 16LBA VEGFR-1 polymorphisms as potential predictors of clinical outcome in bevacizumab-treated patients with metastatic pancreatic cancer | 0.5 | 9 | Citations (PDF) |
| 419 | PP63 Predictive markers in patients with upper gastrointestinal (GI) cancers treated with erlotinib and bevacizumab in a multicenter phase II trial | 0.5 | 0 | Citations (PDF) |
| 420 | Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension | 1.0 | 53 | Citations (PDF) |
| 421 | Prevention of elastase-induced emphysema in placenta growth factor knock-out mice | 4.4 | 25 | Citations (PDF) |
| 422 | 6506 Predictive markers in patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab in a multicenter phase II trial | 0.5 | 0 | Citations (PDF) |
| 423 | Antibiotics may impair hematopoietic recovery after cytotoxic myeloablationBlood, 2009, 113, 1608-1609 | 1.0 | 1 | Citations (PDF) |
| 424 | The FGF system has a key role in regulating vascular integrity | 9.1 | 1 | Citations (PDF) |
| 425 | Hypoxia Induces Dilated Cardiomyopathy in the Chick Embryo: Mechanism, Intervention, and Long-Term Consequences | 2.5 | 104 | Citations (PDF) |
| 426 | Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury | 0.4 | 235 | Citations (PDF) |
| 427 | 439: Intra-amniotic VEGF administration in fetal rats with nitrofen induced lung hypoplasia – A placebo controlled study | 2.5 | 0 | Citations (PDF) |
| 428 | A lifeline for suffocating tissues | 40.1 | 18 | Citations (PDF) |
| 429 | Neurovascular signalling defects in neurodegeneration | 10.0 | 308 | Citations (PDF) |
| 430 | Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism | 16.3 | 405 | Citations (PDF) |
| 431 | Modeling lymphangiogenesis in a three-dimensional culture system | 14.5 | 106 | Citations (PDF) |
| 432 | FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? | 24.2 | 471 | Citations (PDF) |
| 433 | Protective Role of Reactive Astrocytes in Brain Ischemia | 4.9 | 427 | Citations (PDF) |
| 434 | VEGFR‐2‐mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes | 4.0 | 26 | Citations (PDF) |
| 435 | Genetics, epigenetics and pharmaco‐(epi)genomics in angiogenesis | 4.1 | 50 | Citations (PDF) |
| 436 | Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration | 3.7 | 114 | Citations (PDF) |
| 437 | Heterozygous deficiency of the oxygen sensor PHD2 prevents metastasis by inducing vessel normalization | 0.5 | 0 | Citations (PDF) |
| 438 | OC12. Specific inhibition of the VEGF homolog placental growth factor is protective against osteolytic bone metastasis in mice | 10.1 | 0 | Citations (PDF) |
| 439 | 264 DEFICIENCY IN PLACENTAL GROWTH FACTOR CAUSES A DECREASED PORTO-SYSTEMIC COLLATERAL VESSEL FORMATION IN PORTAL HYPERTENSIVE MICE | 2.9 | 0 | Citations (PDF) |
| 440 | Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival | 4.8 | 359 | Citations (PDF) |
| 441 | Elevated levels of placental growth factor represent an adaptive host response in sepsis | 8.1 | 37 | Citations (PDF) |
| 442 | The von Hippel-Lindau Tumor Suppressor Protein and Egl-9-Type Proline Hydroxylases Regulate the Large Subunit of RNA Polymerase II in Response to Oxidative Stress | 2.5 | 104 | Citations (PDF) |
| 443 | Abnormal Sympathoadrenal Development and Systemic Hypotension in <i>PHD3</i><sup><i>−</i>/<i>−</i></sup> Mice | 2.5 | 163 | Citations (PDF) |
| 444 | Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling | 5.6 | 35 | Citations (PDF) |
| 445 | Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway | 4.8 | 209 | Citations (PDF) |
| 446 | Reevaluation of the Role of VEGF-B Suggests a Restricted Role in the Revascularization of the Ischemic Myocardium | 6.2 | 93 | Citations (PDF) |
| 447 | Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination | 3.7 | 110 | Citations (PDF) |
| 448 | The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment | 8.1 | 86 | Citations (PDF) |
| 449 | Metabolism and Therapeutic Angiogenesis | 25.5 | 34 | Citations (PDF) |
| 450 | Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytesBlood, 2008, 111, 4096-4105 | 1.0 | 138 | Citations (PDF) |
| 451 | Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpolesBlood, 2008, 112, 1740-1749 | 1.0 | 47 | Citations (PDF) |
| 452 | Plasmin therapy enhances mobilization of HPCs after G-CSFBlood, 2008, 112, 4048-4050 | 1.0 | 28 | Citations (PDF) |
| 453 | Angiogenesis in the Central Nervous System 2008, , 489-504 | | 2 | Citations (PDF) |
| 454 | Role of Gas6 in erythropoiesis and anemia in mice | 9.1 | 76 | Citations (PDF) |
| 455 | The FGF system has a key role in regulating vascular integrity | 9.1 | 256 | Citations (PDF) |
| 456 | Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice | 9.1 | 212 | Citations (PDF) |
| 457 | Guidance of Vascular and Neuronal Network Formation 2008, , 47-65 | | 0 | Citations (PDF) |
| 458 | Disruption of GAS6-MER Pathway Leads to Defects in Physiological Clearance of Expelled Nuclei from Erythroblasts by Bone Marrow MacrophagesBlood, 2008, 112, 499-499 | 1.0 | 0 | Citations (PDF) |
| 459 | Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction | 19.4 | 115 | Citations (PDF) |
| 460 | Hepatocyte Growth Factor Acts as a Motogen and Guidance Signal for Gonadotropin Hormone-Releasing Hormone-1 Neuronal Migration | 3.7 | 63 | Citations (PDF) |
| 461 | Genetic Deletion of Placenta Growth Factor in Mice Alters Uterine NK Cells | 0.6 | 99 | Citations (PDF) |
| 462 | Ttrap is an essential modulator of Smad3-dependent Nodal signaling during zebrafish gastrulation and left-right axis determination | 3.0 | 39 | Citations (PDF) |
| 463 | uPA deficiency exacerbates muscular dystrophy in MDX mice | 4.8 | 1 | Citations (PDF) |
| 464 | Tetralogy of Fallot and Alterations in Vascular Endothelial Growth Factor-A Signaling and Notch Signaling in Mouse Embryos Solely Expressing the VEGF120 Isoform | 12.8 | 57 | Citations (PDF) |
| 465 | Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish | 3.1 | 133 | Citations (PDF) |
| 466 | uPA deficiency exacerbates muscular dystrophy in <i>MDX</i> mice | 4.8 | 61 | Citations (PDF) |
| 467 | Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity | 7.7 | 179 | Citations (PDF) |
| 468 | NKT Cell-Derived Urokinase-Type Plasminogen Activator Promotes Peripheral Tolerance Associated with Eye | 0.6 | 20 | Citations (PDF) |
| 469 | Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis | 4.8 | 188 | Citations (PDF) |
| 470 | Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumoniaBlood, 2007, 109, 1593-1601 | 1.0 | 107 | Citations (PDF) |
| 471 | Heterogeneity in motoneuron disease | 13.4 | 16 | Citations (PDF) |
| 472 | Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels | 35.1 | 686 | Citations (PDF) |
| 473 | Tumoral and Choroidal Vascularization | 3.6 | 15 | Citations (PDF) |
| 474 | Building in resistance to endothelial cell death | 16.3 | 3 | Citations (PDF) |
| 475 | Similarities Between Angiogenesis and Neural Development: What Small Animal Models Can Tell Us | 0.0 | 54 | Citations (PDF) |
| 476 | Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats | 11.6 | 225 | Citations (PDF) |
| 477 | Neonatal hypoxic preconditioning involves vascular endothelial growth factor | 5.2 | 48 | Citations (PDF) |
| 478 | Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms | 5.2 | 53 | Citations (PDF) |
| 479 | Modification of kidney barrier function by the urokinase receptor | 25.6 | 474 | Citations (PDF) |
| 480 | Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice | 9.1 | 122 | Citations (PDF) |
| 481 | Vascular and Neuronal Development: Intersecting Parallelisms and rossroads 2007, , 159-189 | | 0 | Citations (PDF) |
| 482 | Retinal Angiogenesis and Growth Factors 2007, , 38-77 | | 1 | Citations (PDF) |
| 483 | Gas6 and Its Receptors Are Implicated in Sepsis as Modulators of Innate Immunity.Blood, 2007, 110, 2409-2409 | 1.0 | 0 | Citations (PDF) |
| 484 | Zebrafish and Xenopus tadpoles: Small animal models to study angiogenesis and lymphangiogenesis | 3.1 | 59 | Citations (PDF) |
| 485 | VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease | 4.1 | 86 | Citations (PDF) |
| 486 | Selective Regulation of Arterial Branching Morphogenesis by Synectin | 7.8 | 119 | Citations (PDF) |
| 487 | Another angiogenic gene linked to amyotrophic lateral sclerosis | 10.0 | 29 | Citations (PDF) |
| 488 | A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span | 2.0 | 48 | Citations (PDF) |
| 489 | Gene prioritization through genomic data fusion | 18.1 | 705 | Citations (PDF) |
| 490 | Fishing and frogging for anti-angiogenic drugs 2006, 2, 228-229 | | 13 | Citations (PDF) |
| 491 | VEGF inhibitors make blood | 25.6 | 16 | Citations (PDF) |
| 492 | VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain | 12.4 | 153 | Citations (PDF) |
| 493 | Pulmonary effects of antenatal intratracheal VEGF administration in preterm fetal rabbits | 2.5 | 0 | Citations (PDF) |
| 494 | Evolution of Oxygen and Glucose Concentration Profiles in a Tissue-Mimetic Culture System of Embryonic Stem Cells | 4.2 | 37 | Citations (PDF) |
| 495 | Altered VEGF-A isoform expression during embryogenesis affects arterial, venous and lymphatic differentiation | 2.1 | 0 | Citations (PDF) |
| 496 | VE-Cadherin-Cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells | 1.7 | 355 | Citations (PDF) |
| 497 | Implication of the hypoxia response element of the vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development | 4.2 | 80 | Citations (PDF) |
| 498 | Overlap Syndrome of Cardiac Sodium Channel Disease in Mice Carrying the Equivalent Mutation of Human
SCN5A
-1795insD | 19.4 | 172 | Citations (PDF) |
| 499 | Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis | 19.4 | 9 | Citations (PDF) |
| 500 | Impaired Adipose Tissue Development in Mice With Inactivation of Placental Growth Factor Function | 0.5 | 82 | Citations (PDF) |
| 501 | Altered Na+Channels Promote Pause-Induced Spontaneous Diastolic Activity in Long QT Syndrome Type 3 Myocytes | 12.8 | 61 | Citations (PDF) |
| 502 | Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality | 8.1 | 229 | Citations (PDF) |
| 503 | Endogenous Tissue-Type Plasminogen Activator Is Protective during<i>Escherichia coli</i>-Induced Abdominal Sepsis in Mice | 0.6 | 52 | Citations (PDF) |
| 504 | VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization | 0.7 | 280 | Citations (PDF) |
| 505 | Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis | 19.4 | 94 | Citations (PDF) |
| 506 | Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair | 9.1 | 149 | Citations (PDF) |
| 507 | Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis | 9.1 | 72 | Citations (PDF) |
| 508 | Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts | 9.1 | 271 | Citations (PDF) |
| 509 | A New Mouse Model to Study Acquired Lymphedema | 8.1 | 28 | Citations (PDF) |
| 510 | VEGF, an Angiogenic Factor with Neurotrophic Activity, Useful for Treatment of ALS? 2006, , 239-252 | | 0 | Citations (PDF) |
| 511 | Vascular and Neuronal Effects of VEGF in the Nervous System 2006, , 245-264 | | 0 | Citations (PDF) |
| 512 | Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-β1-induced kidney disease | 5.6 | 55 | Citations (PDF) |
| 513 | Lymph makes you fat | 16.3 | 62 | Citations (PDF) |
| 514 | A genetic Xenopus laevis tadpole model to study lymphangiogenesis | 25.6 | 201 | Citations (PDF) |
| 515 | Common mechanisms of nerve and blood vessel wiring | 40.1 | 894 | Citations (PDF) |
| 516 | Angiogenesis in life, disease and medicine | 40.1 | 2,911 | Citations (PDF) |
| 517 | Genetic evidence for a tumor suppressor role of HIF-2α | 33.4 | 158 | Citations (PDF) |
| 518 | Guidance of vascular and neural network formation | 5.0 | 151 | Citations (PDF) |
| 519 | Downregulation of vascular endothelial-cadherin expression is associated with an increase in vascular tumor growth and hemorrhagic complications | 4.4 | 27 | Citations (PDF) |
| 520 | Role of neural guidance signals in blood vessel navigation | 5.6 | 78 | Citations (PDF) |
| 521 | Testosterone Suppresses Protective Responses of the Liver to Blood-Stage Malaria | 2.8 | 53 | Citations (PDF) |
| 522 | The Zebrafish pob Gene Encodes a Novel Protein Required for Survival of Red Cone Photoreceptor CellsSequence data from this article have been deposited with the EMBL/GenBank Data Libraries under accession no. AY745978. | 4.2 | 38 | Citations (PDF) |
| 523 | Placental Growth Factor Promotes Atherosclerotic Intimal Thickening and Macrophage Accumulation | 19.4 | 138 | Citations (PDF) |
| 524 | Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A | 3.4 | 54 | Citations (PDF) |
| 525 | A Novel Role for Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Embryonic Stem Cells during Hypoxia | 2.3 | 82 | Citations (PDF) |
| 526 | Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture | 7.7 | 66 | Citations (PDF) |
| 527 | Hypoxia-Inducible Factors 1α and 2α Regulate Trophoblast Differentiation | 2.5 | 186 | Citations (PDF) |
| 528 | Novel Mutation in the Per-Arnt-Sim Domain of KCNH2 Causes a Malignant Form of Long-QT Syndrome | 19.4 | 39 | Citations (PDF) |
| 529 | Role of Gas-6 in Adipogenesis and Nutritionally Induced Adipose Tissue Development in Mice | 6.2 | 37 | Citations (PDF) |
| 530 | Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart | 19.4 | 254 | Citations (PDF) |
| 531 | Vascular Remodeling in Mice Lacking the Cytoplasmic Domain of Tissue Factor | 12.8 | 25 | Citations (PDF) |
| 532 | Host Plasminogen Activator Inhibitor-1 Promotes Human Skin Carcinoma Progression in a Stage-Dependent Manner | 7.2 | 36 | Citations (PDF) |
| 533 | Thrombophilia in mice expressing a tissue factor variant lacking its transmembrane and cytosolic domain | 2.1 | 2 | Citations (PDF) |
| 534 | Fibrin-Induced Skin Fibrosis in Mice Deficient in Tissue Plasminogen Activator | 3.6 | 36 | Citations (PDF) |
| 535 | Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in Mice | 3.6 | 136 | Citations (PDF) |
| 536 | Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors | 9.1 | 142 | Citations (PDF) |
| 537 | Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy | 9.1 | 215 | Citations (PDF) |
| 538 | Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A | 3.4 | 0 | Citations (PDF) |
| 539 | The Nuclear Scaffold Protein NIPP1 Is Essential for Early Embryonic Development and Cell Proliferation | 2.5 | 29 | Citations (PDF) |
| 540 | Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer | 0.6 | 247 | Citations (PDF) |
| 541 | The Interferon Inducer Ampligen [Poly(I)-Poly(C
12
U)] Markedly Protects Mice against Coxsackie B3 Virus-Induced Myocarditis | 4.3 | 48 | Citations (PDF) |
| 542 | Under stress, the absence of intermediate filaments from Müller cells in the retina has structural and functional consequences | 3.2 | 115 | Citations (PDF) |
| 543 | Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth | 19.4 | 268 | Citations (PDF) |
| 544 | Genetics in Zebrafish, Mice, and Humans to Dissect Congenital Heart Disease: Insights in the Role of VEGF | 0.0 | 31 | Citations (PDF) |
| 545 | Role of Tissue-Derived Plasminogen Activator (t-PA) in an Excitotoxic Mouse Model of Neonatal White Matter Lesions | 1.9 | 16 | Citations (PDF) |
| 546 | Manipulating angiogenesis in medicine | 7.6 | 159 | Citations (PDF) |
| 547 | Plasmin is not protective in experimental renal interstitial fibrosis1 | 5.6 | 60 | Citations (PDF) |
| 548 | The European dimension for the mouse genome mutagenesis program | 16.3 | 167 | Citations (PDF) |
| 549 | Regulation of angiogenesis by tissue factor cytoplasmic domain signaling | 25.6 | 307 | Citations (PDF) |
| 550 | Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth | 6.6 | 138 | Citations (PDF) |
| 551 | VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model | 40.1 | 523 | Citations (PDF) |
| 552 | The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system | 40.1 | 447 | Citations (PDF) |
| 553 | Genetic spotlight on a blood defect | 40.1 | 8 | Citations (PDF) |
| 554 | Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? | 7.1 | 43 | Citations (PDF) |
| 555 | VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection | 2.3 | 448 | Citations (PDF) |
| 556 | A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis | 7.7 | 621 | Citations (PDF) |
| 557 | Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death | 0.8 | 65 | Citations (PDF) |
| 558 | Title is missing! | 14.0 | 47 | Citations (PDF) |
| 559 | Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity | 2.1 | 54 | Citations (PDF) |
| 560 | Reduction in Arthritis Severity and Modulation of Immune Function in Tissue Factor Cytoplasmic Domain Mutant Mice | 3.6 | 30 | Citations (PDF) |
| 561 | The Cytoplasmic Domain of Tissue Factor Contributes to Leukocyte Recruitment and Death in Endotoxemia | 3.6 | 40 | Citations (PDF) |
| 562 | VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS? | 10.0 | 42 | Citations (PDF) |
| 563 | Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration | 5.2 | 107 | Citations (PDF) |
| 564 | Role of vascular endothelial growth factor receptor 1 in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in mice | 1.2 | 20 | Citations (PDF) |
| 565 | Angiogenesis and lymphangiogenesis: highlights of the past year | 3.0 | 19 | Citations (PDF) |
| 566 | A CLEVER molecule that regulates lymphoctye traffickingBlood, 2004, 104, 3840-3841 | 1.0 | 0 | Citations (PDF) |
| 567 | Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS | 12.4 | 425 | Citations (PDF) |
| 568 | Soluble VEGF isoforms are essential for establishingepiphyseal vascularization and regulating chondrocyte development and survival | 9.1 | 107 | Citations (PDF) |
| 569 | Soluble VEGF isoforms are essential for establishingepiphyseal vascularization and regulating chondrocyte development and survival | 9.1 | 216 | Citations (PDF) |
| 570 | VEGF: a critical player in neurodegeneration | 9.1 | 82 | Citations (PDF) |
| 571 | VEGF: a critical player in neurodegeneration | 9.1 | 198 | Citations (PDF) |
| 572 | Mouse Models to Study Pro-and Antiangiogenic Potential: Novel Roles for PLGF and FLT1 | 0.0 | 0 | Citations (PDF) |
| 573 | Formation of Blood and Lymphatic Vessels: Role of Progenitors 2004, , 455-474 | | 0 | Citations (PDF) |
| 574 | VASCULAR SMOOTH MUSCLE CELL APOPTOSIS IN ATHEROSCLEROTIC PLAQUES IS MEDIATED BY PLASMINOGEN ACTIVATION | 1.2 | 0 | Citations (PDF) |
| 575 | VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis | 2.8 | 137 | Citations (PDF) |
| 576 | Stroma Formation and Angiogenesis by Overexpression of Growth Factors, Cytokines, and Proteolytic Enzymes in Human Skin Grafted to SCID Mice | 0.7 | 37 | Citations (PDF) |
| 577 | Signalling silenced | 40.1 | 7 | Citations (PDF) |
| 578 | VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death | 16.3 | 739 | Citations (PDF) |
| 579 | Angiogenesis in health and disease | 25.6 | 3,504 | Citations (PDF) |
| 580 | VEGF: A modifier of the del22q11 (DiGeorge) syndrome? | 25.6 | 280 | Citations (PDF) |
| 581 | Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 | 25.6 | 643 | Citations (PDF) |
| 582 | Blood vessels and nerves: common signals, pathways and diseases | 19.1 | 428 | Citations (PDF) |
| 583 | Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum–enhanced adhesion formation after laparoscopic surgery in transgenic mice | 1.2 | 41 | Citations (PDF) |
| 584 | Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice | 1.2 | 47 | Citations (PDF) |
| 585 | Role of hypoxia inducible factors 1α and 2α in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice | 1.2 | 53 | Citations (PDF) |
| 586 | 1P-0210 Effects of endogenous placental growth factor on vascular permeability in pathological conditions | 2.1 | 0 | Citations (PDF) |
| 587 | Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) –/– mice | 2.0 | 48 | Citations (PDF) |
| 588 | Title is missing! | 4.6 | 38 | Citations (PDF) |
| 589 | Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1α | 5.6 | 157 | Citations (PDF) |
| 590 | Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy | 0.4 | 50 | Citations (PDF) |
| 591 | VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic | 12.8 | 260 | Citations (PDF) |
| 592 | Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy | 0.4 | 103 | Citations (PDF) |
| 593 | Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β | 0.7 | 48 | Citations (PDF) |
| 594 | Plasminogen Activator Inhibitor-1 Is a Significant Determinant of Renal Injury in Experimental Crescentic Glomerulonephritis | 0.4 | 71 | Citations (PDF) |
| 595 | Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of Antithrombin | 12.8 | 26 | Citations (PDF) |
| 596 | Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II–Induced Abdominal Aortic Aneurysm | 12.8 | 154 | Citations (PDF) |
| 597 | Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata | 3.1 | 93 | Citations (PDF) |
| 598 | Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in ΔKPQ SCN5A (long QT3) mice | 5.6 | 73 | Citations (PDF) |
| 599 | De novo vasculogenesis in the heart | 5.6 | 81 | Citations (PDF) |
| 600 | A critical role of placental growth factor in the induction of inflammation and edema formationBlood, 2003, 101, 560-567 | 1.0 | 142 | Citations (PDF) |
| 601 | Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumoniaBlood, 2003, 102, 934-939 | 1.0 | 109 | Citations (PDF) |
| 602 | Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C–deficient miceBlood, 2003, 101, 4823-4827 | 1.0 | 143 | Citations (PDF) |
| 603 | Mice without uPA, tPA, or Plasminogen Genes Are Resistant to Experimental Choroidal Neovascularization 2003, 44, 1732 | | 44 | Citations (PDF) |
| 604 | Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization 2003, 44, 3186 | | 260 | Citations (PDF) |
| 605 | Dose-Dependent Modulation of Choroidal Neovascularization by Plasminogen Activator Inhibitor Type I: Implications for Clinical Trials 2003, 44, 2791 | | 38 | Citations (PDF) |
| 606 | Neuronal Migration Depends on Intact Peroxisomal Function in Brain and in Extraneuronal Tissues | 3.7 | 53 | Citations (PDF) |
| 607 | Heterozygous deficiency of hypoxia-inducible factor–2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia | 9.1 | 261 | Citations (PDF) |
| 608 | Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? | 9.1 | 117 | Citations (PDF) |
| 609 | Urokinase Receptor Is Necessary for Adequate Host Defense Against Pneumococcal Pneumonia | 0.6 | 158 | Citations (PDF) |
| 610 | Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine Carotid Artery Ligation Model | 6.2 | 61 | Citations (PDF) |
| 611 | Cell Type-Specific Expression of Neuropilins in an MCA-Occlusion Model in Mice Suggests a Potential Role in Post-Ischemic Brain Remodeling | 1.9 | 94 | Citations (PDF) |
| 612 | Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice | 7.7 | 189 | Citations (PDF) |
| 613 | The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent | 0.7 | 243 | Citations (PDF) |
| 614 | Loss of the VEGF164 and VEGF188 Isoforms Impairs Postnatal Glomerular Angiogenesis and Renal Arteriogenesis in Mice | 0.4 | 90 | Citations (PDF) |
| 615 | Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivoBlood, 2002, 99, 2835-2844 | 1.0 | 93 | Citations (PDF) |
| 616 | Smad3-Dependent Induction of Plasminogen Activator Inhibitor-1 in Astrocytes Mediates Neuroprotective Activity of Transforming Growth Factor-β1 against NMDA-Induced Necrosis | 2.2 | 73 | Citations (PDF) |
| 617 | Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders | 5.4 | 215 | Citations (PDF) |
| 618 | Introduction | 5.4 | 0 | Citations (PDF) |
| 619 | Loss of placental growth factor protects mice against vascular permeability in pathological conditions | 2.1 | 76 | Citations (PDF) |
| 620 | Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 | 2.6 | 375 | Citations (PDF) |
| 621 | Vascular Progenitors From Biology to Treatment | 7.2 | 157 | Citations (PDF) |
| 622 | Integrin indecision | 25.6 | 58 | Citations (PDF) |
| 623 | Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice | 25.6 | 616 | Citations (PDF) |
| 624 | Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 | 25.6 | 940 | Citations (PDF) |
| 625 | uPAR: a versatile signalling orchestrator | 31.4 | 1,074 | Citations (PDF) |
| 626 | Placental Growth Factor (PlGF) and Its Receptor Flt‐1 (VEGFR‐1) | 4.5 | 180 | Citations (PDF) |
| 627 | Molecular mechanisms of lymphangiogenesis in health and disease | 33.4 | 608 | Citations (PDF) |
| 628 | Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis | 4.2 | 112 | Citations (PDF) |
| 629 | Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy | 7.4 | 344 | Citations (PDF) |
| 630 | The Development of Blood Vessels: Cellular and Molecular Mechanisms 2002, , 1-20 | | 4 | Citations (PDF) |
| 631 | Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms | 9.1 | 341 | Citations (PDF) |
| 632 | Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms | 9.1 | 206 | Citations (PDF) |
| 633 | Molecular and Cellular Angiogenesis 2002, , 273-287 | | 0 | Citations (PDF) |
| 634 | Molecular mechanisms of blood vessel growth | 5.6 | 778 | Citations (PDF) |
| 635 | Targeted Deletion of the Cytosolic Domain of Tissue Factor in Mice Does Not Affect Development | 2.1 | 43 | Citations (PDF) |
| 636 | Heterogeneous Vascular Dependence of Tumor Cell Populations | 3.6 | 111 | Citations (PDF) |
| 637 | Urokinase but not tissue-type plasminogen activator is involved in collateral artery growth | 2.0 | 0 | Citations (PDF) |
| 638 | Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice | 0.2 | 9 | Citations (PDF) |
| 639 | Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivoBlood, 2001, 97, 1703-1711 | 1.0 | 105 | Citations (PDF) |
| 640 | The Emerging Role of the Bone Marrow-Derived Stem Cells in (Therapeutic) Angiogenesis | 4.4 | 101 | Citations (PDF) |
| 641 | The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse | 1.8 | 31 | Citations (PDF) |
| 642 | Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat | 2.5 | 11 | Citations (PDF) |
| 643 | The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling | 25.6 | 631 | Citations (PDF) |
| 644 | Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis | 25.6 | 385 | Citations (PDF) |
| 645 | Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions | 25.6 | 1,371 | Citations (PDF) |
| 646 | Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration | 16.3 | 878 | Citations (PDF) |
| 647 | In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy | 25.6 | 529 | Citations (PDF) |
| 648 | Growing better blood vessels | 18.1 | 67 | Citations (PDF) |
| 649 | Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome | 25.6 | 223 | Citations (PDF) |
| 650 | Jeffrey Michael Isner 1947-2001 | 25.6 | 0 | Citations (PDF) |
| 651 | Creating unique blood vessels | 40.1 | 25 | Citations (PDF) |
| 652 | Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects | 7.7 | 509 | Citations (PDF) |
| 653 | Bmx Tyrosine Kinase Has a Redundant Function Downstream of Angiopoietin and Vascular Endothelial Growth Factor Receptors in Arterial Endothelium | 2.5 | 74 | Citations (PDF) |
| 654 | Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis | 0.6 | 53 | Citations (PDF) |
| 655 | Hypoxia-inducible Factor-2α (HIF-2α) Is Involved in the Apoptotic Response to Hypoglycemia but Not to Hypoxia | 2.3 | 94 | Citations (PDF) |
| 656 | The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin | 4.8 | 285 | Citations (PDF) |
| 657 | Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization | 0.7 | 29 | Citations (PDF) |
| 658 | Blood Coagulation Factor X Deficiency Causes Partial Embryonic Lethality and Fatal Neonatal Bleeding in Mice | 4.4 | 149 | Citations (PDF) |
| 659 | Transgenic mouse models in angiogenesis and cardiovascular disease 2000, 190, 387-405 | | 109 | Citations (PDF) |
| 660 | PR39, a peptide regulator of angiogenesis | 25.6 | 333 | Citations (PDF) |
| 661 | Mechanisms of angiogenesis and arteriogenesis | 25.6 | 3,457 | Citations (PDF) |
| 662 | VEGF gene therapy: stimulating angiogenesis or angioma-genesis? | 25.6 | 318 | Citations (PDF) |
| 663 | Angiogenesis in cancer and other diseases | 40.1 | 7,545 | Citations (PDF) |
| 664 | One cell, two fates | 40.1 | 63 | Citations (PDF) |
| 665 | Roles of urokinase type plasminogen activator in a brain stab wound | 2.5 | 21 | Citations (PDF) |
| 666 | The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: Insights from genetic studies | 4.9 | 58 | Citations (PDF) |
| 667 | Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-ABlood, 2000, 95, 1979-1987 | 1.0 | 48 | Citations (PDF) |
| 668 | Inactivation of the Peroxisomal Multifunctional Protein-2 in Mice Impedes the Degradation of Not Only 2-Methyl-branched Fatty Acids and Bile Acid Intermediates but Also of Very Long Chain Fatty Acids | 2.3 | 168 | Citations (PDF) |
| 669 | Transcription Factor Hepatocyte Nuclear Factor 6 Regulates Pancreatic Endocrine Cell Differentiation and Controls Expression of the Proendocrine Gene <i>ngn3</i> | 2.5 | 284 | Citations (PDF) |
| 670 | Disruption of the Plasminogen Gene in Mice Abolishes Wound Healing after Myocardial Infarction | 3.6 | 133 | Citations (PDF) |
| 671 | Molecular Basis of Angiogenesis: Role of VEGF and VE‐Cadherin | 4.5 | 229 | Citations (PDF) |
| 672 | Proteinases in cardiovascular aneurysms and rupture: targets for therapy? | 9.1 | 34 | Citations (PDF) |
| 673 | Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility | 9.1 | 130 | Citations (PDF) |
| 674 | F 2000, , 90-143 | | 0 | Citations (PDF) |
| 675 | A Role of Plasminogen in Atherosclerosis and Restenosis Models in Mice | 4.4 | 43 | Citations (PDF) |
| 676 | Structure-Function Analyses of Thrombomodulin by Gene-Targeting in Mice: The Cytoplasmic Domain Is Not Required for Normal Fetal DevelopmentBlood, 1999, 93, 3442-3450 | 1.0 | 33 | Citations (PDF) |
| 677 | Ovulation in Plasminogen-Deficient Mice<sup>1</sup> | 2.7 | 49 | Citations (PDF) |
| 678 | Plasminogen Is Not Required for Neointima Formation in a Mouse Model of Vein Graft Stenosis | 12.8 | 33 | Citations (PDF) |
| 679 | Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure | 25.6 | 698 | Citations (PDF) |
| 680 | Controlling the cellular brakes | 40.1 | 51 | Citations (PDF) |
| 681 | Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 | 25.6 | 570 | Citations (PDF) |
| 682 | Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1 | 0.2 | 14 | Citations (PDF) |
| 683 | Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient mice | 1.9 | 4 | Citations (PDF) |
| 684 | Plasminogen and cell migration in vivo | 0.2 | 30 | Citations (PDF) |
| 685 | Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis | 35.1 | 1,088 | Citations (PDF) |
| 686 | Animal models of cardiovascular disease | 1.2 | 0 | Citations (PDF) |
| 687 | Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit | 9.1 | 44 | Citations (PDF) |
| 688 | Ovulation in Plasminogen-Deficient Mice | 2.7 | 16 | Citations (PDF) |
| 689 | Molecular Analysis of Vascular Development and Disorders | 0.0 | 0 | Citations (PDF) |
| 690 | Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis | 40.1 | 2,404 | Citations (PDF) |
| 691 | Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization | 25.6 | 580 | Citations (PDF) |
| 692 | Vascular development and disorders: Molecular analysis and pathogenic insights | 5.6 | 96 | Citations (PDF) |
| 693 | Urokinase mediates bFGF-induced vascular smooth muscle cell migration under the control of TGFβ | 0.2 | 1 | Citations (PDF) |
| 694 | Molecules in focus Tissue factor | 2.6 | 54 | Citations (PDF) |
| 695 | Development and Disease in Proteinase-Deficient Mice | 2.4 | 160 | Citations (PDF) |
| 696 | Function of the Plasminogen/Plasmin and Matrix Metalloproteinase Systems After Vascular Injury in Mice With Targeted Inactivation of Fibrinolytic System Genes | 6.2 | 205 | Citations (PDF) |
| 697 | Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice | 4.8 | 117 | Citations (PDF) |
| 698 | Plasminogen Deficiency Differentially Affects Recruitment of Inflammatory Cell Populations in MiceBlood, 1998, 91, 2005-2009 | 1.0 | 205 | Citations (PDF) |
| 699 | Cloning and Characterization of a cDNA Encoding Murine Coagulation Factor X | 4.4 | 10 | Citations (PDF) |
| 700 | Nucleotide Structure and Characterization of the Murine Gene Encoding Anticoagulant Protein C | 4.4 | 5 | Citations (PDF) |
| 701 | Role of Endothelial versus Smooth Muscle Cells in Blood Vessel Formation 1998, , 287-303 | | 0 | Citations (PDF) |
| 702 | Role of the Fibrinolytic and the Coagulation System in the Formation and Disorders of Blood Vessels | 0.0 | 0 | Citations (PDF) |
| 703 | Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis | 8.1 | 175 | Citations (PDF) |
| 704 | Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells | 2.3 | 55 | Citations (PDF) |
| 705 | Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis | 4.1 | 27 | Citations (PDF) |
| 706 | Insights from gene-inactivation studies of the coagulation and plasminogen | 0.2 | 7 | Citations (PDF) |
| 707 | Molecular analysis of blood vessel formation and disease | 3.9 | 78 | Citations (PDF) |
| 708 | Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing MiceBlood, 1997, 90, 1527-1534 | 1.0 | 37 | Citations (PDF) |
| 709 | Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System | 4.5 | 113 | Citations (PDF) |
| 710 | A mouse model for Zellweger syndrome | 16.3 | 238 | Citations (PDF) |
| 711 | Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation | 16.3 | 560 | Citations (PDF) |
| 712 | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding | 40.1 | 212 | Citations (PDF) |
| 713 | Genetic Analysis of Blood Vessel Formation | 7.2 | 39 | Citations (PDF) |
| 714 | Studies of Mice Lacking Plasminogen Activator Gene Function Suggest that Plasmin Production Prior to Ovulation Exceeds the Amount Needed for Optimal Ovulation Efficiency | 0.3 | 18 | Citations (PDF) |
| 715 | Polyoma Middle T-induced Vascular Tumor Formation: The Role of the Plasminogen Activator/Plasmin System | 4.8 | 59 | Citations (PDF) |
| 716 | Inhibitory Role of Plasminogen Activator Inhibitor-1 in Arterial Wound Healing and Neointima Formation | 19.4 | 190 | Citations (PDF) |
| 717 | Urokinase but Not Tissue Plasminogen Activator Mediates Arterial Neointima Formation in Mice | 12.8 | 159 | Citations (PDF) |
| 718 | Biological Effects of Targeted Gene Inactivation and Gene Transfer of the Coagulation and Fibrinolytic Systems in Mice 1997, , 79-99 | | 0 | Citations (PDF) |
| 719 | Nucleotide Structure and Characterization of the Murine Blood Coagulation Factor VII Gene | 4.4 | 12 | Citations (PDF) |
| 720 | Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. | 7.7 | 310 | Citations (PDF) |
| 721 | Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice | 0.3 | 35 | Citations (PDF) |
| 722 | Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | 40.1 | 3,457 | Citations (PDF) |
| 723 | Role of tissue factor in embryonic blood vessel development | 40.1 | 593 | Citations (PDF) |
| 724 | Gene Manipulation and Transfer of the Plasminogen and Coagulation System in Mice | 3.1 | 49 | Citations (PDF) |
| 725 | Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor | 5.1 | 10 | Citations (PDF) |
| 726 | Characterization of a cDNA Encoding Murine Coagulation Factor VII | 4.4 | 19 | Citations (PDF) |
| 727 | Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals | 7.2 | 29 | Citations (PDF) |
| 728 | Gene targeting and gene transfer studies of the plaeminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis | 0.7 | 76 | Citations (PDF) |
| 729 | Generation of Monoclonal Antibodies against Autologous Proteins in Gene-inactivated Mice | 2.3 | 45 | Citations (PDF) |
| 730 | Gene Targeting and Gene Transfer Studies of the Biological Role of the Plasminogen/Plasmin System | 4.4 | 47 | Citations (PDF) |
| 731 | Biological Effects of Combined Inactivation of Plasminogen Activator and Plasminogen Activator Inhibitor-1 Gene Function in Mice | 4.4 | 21 | Citations (PDF) |
| 732 | Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice | 19.4 | 323 | Citations (PDF) |
| 733 | Physiological consequences of loss of plasminogen activator gene function in mice | 40.1 | 949 | Citations (PDF) |
| 734 | Evaluation of the plasminogen/plasmin system in transgenic mice | 0.3 | 28 | Citations (PDF) |
| 735 | Biological effects of inactivation of the genes for tissue-type plasminogen activator, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in mice | 0.3 | 2 | Citations (PDF) |
| 736 | Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. | 9.1 | 295 | Citations (PDF) |
| 737 | Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. | 9.1 | 326 | Citations (PDF) |
| 738 | Interferon-7 Inhibits Stimulated Adrenocorticotropin, Prolactin, and Growth Hormone Secretion in Normal Rat Anterior Pituitary Cell Cultures* | 2.7 | 80 | Citations (PDF) |
| 739 | Regulation and Cellular Localization of the Membrane Bound Thyrotropin-Releasing Hormone-Degrading Enzyme in Primary Cultures of Neuronal, Glial and Adenohypophyseal Cells* | 2.7 | 59 | Citations (PDF) |
| 740 | Interleukin-1β inhibits acetylcholine synthesis in the pituitary corticotropic cell line AtT20 | 2.5 | 17 | Citations (PDF) |
| 741 | Synthesis and Release of Acetylcholine by Normal and Tumoral Pituitary Corticotrophs* | 2.7 | 42 | Citations (PDF) |
| 742 | Cell-to-cell communication in peptide target cells of anterior pituitary | 1.0 | 66 | Citations (PDF) |
| 743 | Immunocytochemical and Pharmacological Evidence for an Intrinsic Cholinomimetic System Modulating Prolactin and Growth Hormone Release in Rat Pituitary* | 2.7 | 41 | Citations (PDF) |
| 744 | Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes | 1.6 | 37 | Citations (PDF) |
| 745 | Differential roles for the oxygen sensing enzymes PHD1 and PHD3 in the regulation of neutrophil metabolism and function | 1.0 | 0 | Citations (PDF) |
